View |
|
DR-XY42967
|
Memantine HCl
|
Memry
|
10 mg
|
Film-Coated Tablet
|
Anti-dementia Drug
|
Bilim Ilac San. Ve Tic. A.S.
|
Turkey
|
Renewal
|
03 December 2023
|
18 November 2028
|
View |
|
DR-XY42971
|
Clotrimazole
|
Clotribex
|
30mg/g (3%)
|
Topical Cream
|
Antifungal (Imidazole)
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
19 December 2023
|
19 November 2028
|
View |
|
DR-XY42977
|
Co-amoxiclav
|
Klavic
|
228.5 mg per 5 mL
|
Powder For Suspension
|
Antibacterial
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Renewal
|
06 February 2019
|
18 November 2028
|
View |
|
DR-XY42978
|
Phenylephrine Hydrochloride + Paracetamol
|
Neozep Non-Drowsy
|
10mg/500 mg
|
Tablet
|
Nasal Decongestant/Analgesic/Antipyretic
|
PT. Medifarma Laboratories
|
Indonesia
|
Automatic Renewal
|
12 December 2022
|
18 November 2028
|
View |
DR-XY42983_PI_01.pdf
|
DR-XY42983
|
Azithromycin (as dihydrate)
|
Geozit
|
200mg/5 mL
|
Powder For Oral Suspension
|
Antibacterials
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
21 July 2023
|
19 November 2028
|
View |
|
DR-XY42988
|
Phenylephrine Hydrochloride + Brompheniramine maleate
|
Sidrocine
|
6.25mg+2mg per mL
|
Syrup (Oral Drops)
|
Sympathomimetics used as decongestants
|
Pharmatec Pakistan Private Limited
|
Pakistan
|
Renewal
|
13 November 2018
|
21 November 2028
|
View |
|
DR-XY42989
|
Potassium Chloride
|
Sitiklor
|
100mg/mL (1.34 meq/mL)
|
Concentrated Solution For Injection (Iv)
|
Electrolyte and IV Additive Solutions
|
CSPC Ouyi Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
13 November 2018
|
13 November 2028
|
View |
|
DR-XY42998
|
Magnesium Sulfate
|
Epsium
|
250 mg/mL
|
Solution For Injection (I.M./I.V.)
|
Anitconvulsant/Antiepileptic
|
Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
28 February 2023
|
22 November 2028
|
View |
|
DR-XY43003
|
Fentanyl (As Citrate)
|
Sublimax
|
50 mcg/mL
|
Solution for Injection (IM/IV)
|
Opioid Analgesic
|
Yichang Humanwell Pharmaceutical Co., Ltd.
|
China
|
Initial (Variation)
|
06 June 2022
|
22 November 2027
|
View |
|
DR-XY43004
|
Paracetamol
|
Paragesic
|
250 mg
|
Suppository
|
Analgesic / Antipyretic
|
Bliss GVS Pharma Ltd.
|
India
|
Renewal
|
03 December 2023
|
22 November 2028
|
View |
|
DR-XY43007
|
Losartan Potassium
|
Medzart
|
50 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor Blocker
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
22 July 2023
|
22 November 2028
|
View |
|
DR-XY43008
|
Losartan Potassium
|
Medzart
|
100 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor Blocker
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
21 July 2023
|
22 November 2028
|
View |
|
DR-XY43010
|
Oxytocin
|
Utexyn
|
10 IU/mL
|
Solution For Injection (Im/Iv)
|
Oxytocics (Uterine Stimulants)
|
Gland Pharma Limited
|
India
|
Renewal
|
02 July 2019
|
21 November 2028
|
View |
|
DR-XY43017
|
Prednisolone (As Sodium Phosphate)
|
Neopred
|
20 mg/5 mL
|
Syrup
|
CORTICOSTEROID
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
13 December 2022
|
22 January 2028
|
View |
|
DR-XY43033
|
Adapalene
|
Differin
|
3mg/g (0.3%)
|
Topical Gel
|
Anti-acne
|
Galderma Brasil Ltda.
|
Brazil
|
Renewal
|
15 February 2024
|
28 November 2028
|
View |
|
DR-XY43043
|
Ursodeoxycholic Acid
|
URSOFALK
|
500mg
|
Film-Coated Tablet
|
Bile Salt
|
Losan Pharma GmbH
|
Germany
|
Renewal
|
23 June 2023
|
29 November 2028
|
View |
|
DR-XY43049
|
Cefuroxime (as axetil)
|
Euroxime
|
125 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Second Generation Cephalosporin)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
31 January 2019
|
03 December 2028
|
View |
|
DR-XY43055
|
Mometasone furoate
|
Rynorex
|
50 mcg/ spray
|
Metered Dose Nasal Spray
|
Nasal Corticosteroid
|
Square Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
05 November 2023
|
05 December 2028
|
View |
|
DR-XY43060
|
Loratadine
|
Lordam
|
10mg
|
Tablet
|
Antihistamines (H1-Receptor Antagonists)
|
Nabiqasim Industries (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
25 May 2022
|
05 December 2026
|
View |
|
DR-XY43066
|
Salmeterol (as xinafoate) + Fluticasone propionate
|
Salmetide
|
50 mcg/500 mcg
|
Dry Powder for Inhalation
|
Beta-2 Adrenoceptor Agonist/ Corticosteroid
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
31 January 2019
|
09 December 2028
|